Share Issue/Capital Change • Mar 11, 2010
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 11 March 2010 11:30
Geratherm Medical AG: Geratherm Medical AG successfully completes capital increase
Geratherm Medical AG / Capital Increase
11.03.2010 11:30
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
Ad-hoc release pursuant to section 15 of the Securities Trading Act (WpHG)
Capital increase
Geratherm Medical AG successfully completes capital increase
Capital stock raised by 10 percent
Strong demand among national and international investors
Geschwenda, 11 March 2010 - Geratherm Medical AG (ISIN: DE0005495626) has
successfully completed a capital increase of up to 10% of the existing
capital stock from approved capital, excluding shareholders' subscription
rights.
As part of the accelerated book building process, all 450,000 new shares
being offered were successfully placed with qualified institutional
investors both in Germany and abroad at EUR 8.00 per share. The capital
increase therefore generated gross proceeds of around EUR 3.6 million.
By broadening the equity capital base, the shareholder structure was
substantially expanded in Germany and abroad. With equity capital in excess
of 80%, the Company believes that its strong balance sheet ratios put it in
an excellent position to sustain its buoyant growth track from 2009. The
inflow of funds is primarily intended to go towards further innovative
product developments and also be invested in inorganic growth.
The Company's capital stock will be EUR 4,950,000.00 after the capital
increase has been entered into the commercial register. The new shares are
being released for trading in the regulated market (Prime Standard) of the
Frankfurt Stock Exchange without prospectus.
The capital increase, which was considerably oversubscribed by national and
international investors, was supported by Close Brothers Seydler Bank AG,
Frankfurt am Main as sole lead manager und sole bookrunner.
The Managing Board
Short company profile:
Geratherm Medical is an internationally operating medical products
enterprise with the business areas 'Temperature Management', 'Cardio' and
'Respiratory'. Our company's roots are in temperature measurement in the
medical sphere. In this business area we offer a broad spectrum of
products, most of which have unique selling points. We supply our
customers/patients with high-quality products ranging from thermometers to
complex warming systems for use in the operating theatre and by emergency
rescue services. In the Cardio business area we concentrate on the
development of products for the detection of atrial fibrillation as a
measure to prevent strokes. The Respiratory segment develops and markets
products for the assessment of pulmonary function.
In all three business areas, Geratherm has patent-protected basic
technologies at its disposal. We regard ourselves as a research-based
medical products company with a clear focus on medical diagnostic devices
that generate vital data.
Geratherm shares have been listed in the Prime Standard segment of the
Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues
to be represented in the German Entrepreneurial Index and in the German
Health-Care Index.
Company contact:
Geratherm Medical AG
Investor Relations
Fahrenheitstraße 1
98716 Geschwenda
Tel. +49 (0)36205/98 111
Email: [email protected]
www.geratherm.com
ISIN: DE 000 549 562 6
Cusip number: 549 562
Segment: Frankfurter Wertpapierbörse/Geregelter Markt/Prime Standard
Trading place: Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, München,
Stuttgart
DISCLAIMER:
THIS PUBLICATION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT INTENDED,
AND SHOULD NOT BE CONSTRUED, AS AN OFFER TO SELL OR A SOLICITATION OF AN
OFFER TO BUY OR SUBSCRIBE FOR ANY SECURITIES. NO OFFER OF SECURITIES OF
GERATHERM MEDICAL AG, GESCHWENDA IS BEING, OR WILL BE, MADE IN ANY
JURISDICTION.
THIS PUBLICATION AND THE INFORMATION CONTAINED HEREIN IS NOT FOR
PUBLICATION OR DISTRI-BUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED
STATES, CANADA, AUSTRALIA OR JAPAN.
THE SECURITIES OF THE COMPANY DESCRIBED HEREIN HAVE NOT BEEN AND WILL NOT
BE REGISTE-RED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE
'SECURITIES ACT'), OR THE LAWS OF ANY STATE, AND MAY NOT BE OFFERED OR SOLD
WITHIN THE UNITED STATES, EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIRE-MENTS OF THE
SECURITIES ACT AND APPLICABLE STATE LAWS. THERE WILL BE NO PUBLIC
OFFE-RING OF SECURITIES IN THE UNITED STATES.
11.03.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Deutschland
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: [email protected]
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Hamburg, Stuttgart
End of News DGAP News-Service
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.